Table 3.
Number of diabetic macrovascular complication and all-cause death at a median follow-up of 36 months
| Cumulative incidence | Incidence rate (cases/100 person-years) | ||||
|---|---|---|---|---|---|
| No. of events | Rate (%) | Estimate | 95 % CI* | Person-years | |
| RAMP-DM group (N = 9,094) | |||||
| CVD | 399 | 4.39 | 1.495 | (1.352, 1.650) | 26,681 |
| CHD | 170 | 1.87 | 0.631 | (0.540, 0.733) | 26,938 |
| Stroke | 205 | 2.25 | 0.763 | (0.662, 0.874) | 26,882 |
| Heart Failure | 72 | 0.79 | 0.266 | (0.208, 0.335) | 27,040 |
| All-cause mortality | 202 | 2.22 | 0.745 | (0.646, 0.856) | 27,101 |
| Control group (N = 9,094) | |||||
| CVD | 608 | 6.69 | 2.420 | (2.231, 2.620) | 25,127 |
| CHD | 280 | 3.08 | 1.099 | (0.974, 1.235) | 25,482 |
| Stroke | 309 | 3.40 | 1.216 | (1.084, 1.359) | 25,418 |
| Heart failure | 125 | 1.37 | 0.487 | (0.405, 0.580) | 25,660 |
| All-cause mortality | 552 | 6.07 | 2.144 | (1.968, 2.330) | 25,752 |
RAMP-DM multi-disciplinary risk assessment and management-diabetes mellitus. CVD cardiovascular disease, CHD coronary heart disease and CI confidence interval.
* The 95 % CI was constructed based on Poisson distribution.